Skip to main content

Table 4 Summary of tablet acceptance for dogs administered Credelio Plus tablets in the safety population for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA

From: Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA

Treatment group

Number of

dogs

Tablet consumed free choice or with small amount of food (%)

Manually dosed [pilled] (%)

Credelio Plus tablets

159

1277 (81.8%)

285 (18.2%)